Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course.
about
Azithromycin for acute lower respiratory tract infectionsClinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumoniaAzithromycin for acute lower respiratory tract infectionsAzithromycin for acute lower respiratory tract infectionsQ feverBTS Guidelines for the Management of Community Acquired Pneumonia in AdultsClinical features of culture-proven Mycoplasma pneumoniae infections at King Abdulaziz University Hospital, Jeddah, Saudi ArabiaGuidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and preventionThe burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 studyEfficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.'Atypical pneumonia'. Why this term may be better left unsaid.Amoebae as training grounds for intracellular bacterial pathogens.Importance of atypical pathogens of community-acquired pneumonia.A review of clinical trials with fluoroquinolones with an emphasis on new agents.Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections.Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infectionPneumonia and pregnancy.Multiplexed serology in atypical bacterial pneumonia.Parachlamydiaceae: potential emerging pathogensProviding better care for patients who may have pneumonia.Management of community-acquired pneumonia: a focus on conversion from hospital to the ambulatory setting.Epidemiology of community- and nursing home-acquired pneumonia in older adults.Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomesRisk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays.Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia.Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study.A bovine model of a respiratory Parachlamydia acanthamoebae infection.Epidemiology of respiratory infections caused by atypical bacteria in two Kenyan refugee camps.Acute intrahepatic cholestasis accompanied with Chlamydophila pneumoniae infection.Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCRChlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infectionThe pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussiComparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae.ATP/ADP translocases: a common feature of obligate intracellular amoebal symbionts related to Chlamydiae and RickettsiaeThe emerging role of atypical pathogens in community-acquired pneumonia.Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland.The bacterial pneumonias: a new treatment paradigm.A cross-sectional study to assess the long-term health status of patients with lower respiratory tract infections, including Q fever.Clinical features of Q fever pneumonia.
P2860
Q24187354-0AEF36E7-FBC8-4C56-A329-B26E6D859200Q24197968-93EC5B74-681C-4C5D-B1B1-80D9637DF26FQ24242162-C80D40FF-B633-4A4D-8F9A-860C79145E14Q24245859-2ABFF3CC-F98C-4EA8-9A03-3D0E74EF1496Q24550722-27CFD8E4-1920-4825-960D-DCD58402EA1BQ24675547-8FFD9586-C210-4427-962D-290BE5997B1BQ24801405-107D56D5-A4DC-45A2-8909-ACFF8A289AFBQ28201389-7656E93D-7792-485A-9C97-5E0170C98CB1Q33347005-F1830AF0-7682-4E6E-8317-02A241D1474EQ33501357-169CA859-4D5A-48AE-BECF-33394328B03FQ33605262-27656285-9D62-46B3-9E7F-78EA55423371Q33722169-F6CCC6E9-1021-42BF-ABBC-1FB6FF080F94Q34030766-64D6E8EE-E532-4820-95DC-E76F2FE346C7Q34074724-AE918492-0825-40BB-8925-79AE7E96F03CQ34141064-62E0C196-0219-471F-B640-AE2DF679FB5EQ34169255-CF551CDE-9AF3-4488-9A3A-5DD8A1470981Q34223608-683126F3-0A9A-4D56-9717-7FFA82F10D81Q34225342-FE5CA902-9496-4A20-A5E5-F2727474886CQ34582884-085462B8-EECA-40E3-95AE-2DFB65B834C8Q34650053-A5859897-67D1-43A0-AACB-6D6A62DC7520Q35532824-62D85EC7-F05C-4A5B-86F3-5FEC208A84A5Q35627633-D3B0CC13-229B-418E-9DE2-A6D010DAB53DQ36140683-D54CAD31-43D2-4CDD-9B1B-EA280C3D3477Q36291044-C284C923-1E56-4DBF-9A61-16EA97D50508Q36883429-104B1022-DEB3-4E42-B2C5-E00D7F2B12B4Q37075186-FCE2ECC6-58E8-4860-A667-ECCF89FA183CQ37313129-05C2187A-8BFB-4A29-B233-A962474DB89AQ37844044-45982E65-7752-4612-B9F5-8FEC2CD6EB3EQ37850711-44899FFB-8E38-49A8-8810-A117A7B15E7BQ37851139-E86DEC32-1858-465A-8AB6-1028BAC55761Q37858428-4FEA0D6E-BDCC-4692-945A-098AEF6E8429Q37861022-189C1103-794B-4344-8A6A-D9E5BD0A1B60Q37865550-B61C4795-B8B6-4E6B-988F-FBC6A681A6F5Q37866691-BE0E3632-D7B2-4544-9220-E68D5709FCA5Q37867878-B2FBDD43-B79D-4A5B-8727-E37E6C20241FQ37872805-97927350-0A2D-41C2-83C3-E89E20DB7467Q37874501-0E8A6AFE-1AC8-43EE-83DA-56133ECED17DQ38307688-CE6EF6C7-5EC0-4BA4-A966-4CB809F16234Q40214542-82475A29-81F7-42B5-BDE2-4D8FEA5302E5Q40532526-7933DF3D-0F30-412E-A65F-EE5F850C24A1
P2860
Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Ambulatory patients with commu ...... al agents and clinical course.
@en
Ambulatory patients with commu ...... al agents and clinical course.
@nl
type
label
Ambulatory patients with commu ...... al agents and clinical course.
@en
Ambulatory patients with commu ...... al agents and clinical course.
@nl
prefLabel
Ambulatory patients with commu ...... al agents and clinical course.
@en
Ambulatory patients with commu ...... al agents and clinical course.
@nl
P2093
P1476
Ambulatory patients with commu ...... al agents and clinical course.
@en
P2093
P304
P356
10.1016/S0002-9343(96)00255-0
P407
P577
1996-11-01T00:00:00Z